J S Read

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi The immunogenicity of Haemophilus influenzae type b conjugate vaccines in children born to human immunodeficiency virus-infected women. Women and Infants Transmission Study Group
    J S Read
    Pediatric, Adolescent, and Maternal AIDS Branch, National Institute of Child Health and Human Development, Bethesda, MD 20892 7510, USA
    Pediatr Infect Dis J 17:391-7. 1998
  2. ncbi Serum vitamin A concentrations in a North American cohort of human immunodeficiency virus type 1-infected children. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group
    J S Read
    Pediatric, Adolescent and Maternal AIDS Branch, National Institute of Child Health and Human Development, Bethesda, MD 20892 7510, USA
    Pediatr Infect Dis J 18:134-42. 1999
  3. ncbi Quantification of human immunodeficiency virus type 1 p24 antigen and antibody rivals human immunodeficiency virus type 1 RNA and CD4+ enumeration for prognosis. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical
    J S Read
    Pediatric, Adolescent, and Maternal AIDS Branch, National Institute of Child Health and Human Development, Bethesda, MD 20892 7510, USA
    Pediatr Infect Dis J 19:544-51. 2000
  4. ncbi Cesarean section delivery to prevent vertical transmission of human immunodeficiency virus type 1. Associated risks and other considerations
    J S Read
    Pediatric, Adolescent, and Maternal AIDS Branch, National Institute of Child Health and Human Development, Bethesda, Maryland 20892 7510, USA
    Ann N Y Acad Sci 918:115-21. 2000
  5. ncbi Mode of delivery and postpartum morbidity among HIV-infected women: the women and infants transmission study
    J S Read
    Pediatric, Adolescent, and Maternal AIDS Branch, National Institute of Child Health and Human Development, Bethesda, Maryland 20892 7510, USA
    J Acquir Immune Defic Syndr 26:236-45. 2001
  6. ncbi Alternatives to HIV-1 RNA concentration and CD4 count to predict mortality in HIV-1-infected children in resource-poor settings
    L M Mofenson
    Pediatric, Adolescent, and Maternal AIDS Branch, National Institute of Child Health and Human Development, National Institutes of Health, 6100 Executive Boulevard, Rockville, MD 20852, USA
    Lancet 362:1625-7. 2003
  7. ncbi Pharmacokinetics of new 625 mg nelfinavir formulation during pregnancy and postpartum
    J S Read
    Pediatric, Adolescent and Maternal AIDS Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892 7510, USA
    HIV Med 9:875-82. 2008
  8. ncbi Acceptance of HIV-1 education & voluntary counselling/testing by & seroprevalence of HIV-1 among, pregnant women in rural south India
    N M Samuel
    The Tamil Nadu Dr M G R Medical University, Chennai, India
    Indian J Med Res 125:49-64. 2007
  9. ncbi Chronic administration of nevirapine during pregnancy: impact of pregnancy on pharmacokinetics
    E V Capparelli
    San Diego Schools of Medicine and Pharmacy and Pharmaceutical Sciences, University of California, San Diego, CA 92103, USA
    HIV Med 9:214-20. 2008

Collaborators

Detail Information

Publications9

  1. ncbi The immunogenicity of Haemophilus influenzae type b conjugate vaccines in children born to human immunodeficiency virus-infected women. Women and Infants Transmission Study Group
    J S Read
    Pediatric, Adolescent, and Maternal AIDS Branch, National Institute of Child Health and Human Development, Bethesda, MD 20892 7510, USA
    Pediatr Infect Dis J 17:391-7. 1998
    ..The objectives of the study were to evaluate the immunogenicity of Hib conjugate vaccines among HIV-infected children according to clinical and immunologic disease progression as well as viral load...
  2. ncbi Serum vitamin A concentrations in a North American cohort of human immunodeficiency virus type 1-infected children. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group
    J S Read
    Pediatric, Adolescent and Maternal AIDS Branch, National Institute of Child Health and Human Development, Bethesda, MD 20892 7510, USA
    Pediatr Infect Dis J 18:134-42. 1999
    ....
  3. ncbi Quantification of human immunodeficiency virus type 1 p24 antigen and antibody rivals human immunodeficiency virus type 1 RNA and CD4+ enumeration for prognosis. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical
    J S Read
    Pediatric, Adolescent, and Maternal AIDS Branch, National Institute of Child Health and Human Development, Bethesda, MD 20892 7510, USA
    Pediatr Infect Dis J 19:544-51. 2000
    ....
  4. ncbi Cesarean section delivery to prevent vertical transmission of human immunodeficiency virus type 1. Associated risks and other considerations
    J S Read
    Pediatric, Adolescent, and Maternal AIDS Branch, National Institute of Child Health and Human Development, Bethesda, Maryland 20892 7510, USA
    Ann N Y Acad Sci 918:115-21. 2000
    ..In summary, the benefit of ECS must be weighed against potential risks, and issues such as cost-effectiveness also should be taken into consideration...
  5. ncbi Mode of delivery and postpartum morbidity among HIV-infected women: the women and infants transmission study
    J S Read
    Pediatric, Adolescent, and Maternal AIDS Branch, National Institute of Child Health and Human Development, Bethesda, Maryland 20892 7510, USA
    J Acquir Immune Defic Syndr 26:236-45. 2001
    ....
  6. ncbi Alternatives to HIV-1 RNA concentration and CD4 count to predict mortality in HIV-1-infected children in resource-poor settings
    L M Mofenson
    Pediatric, Adolescent, and Maternal AIDS Branch, National Institute of Child Health and Human Development, National Institutes of Health, 6100 Executive Boulevard, Rockville, MD 20852, USA
    Lancet 362:1625-7. 2003
    ..0001) and serum albumin (p=0.0107) independently predicted mortality. Further assessment of these markers is warranted in resource-poor settings...
  7. ncbi Pharmacokinetics of new 625 mg nelfinavir formulation during pregnancy and postpartum
    J S Read
    Pediatric, Adolescent and Maternal AIDS Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892 7510, USA
    HIV Med 9:875-82. 2008
    ..Our objective was to evaluate the pharmacokinetics of nelfinavir (NFV) (625 mg tablets) 1250 mg twice daily during pregnancy and postpartum...
  8. ncbi Acceptance of HIV-1 education & voluntary counselling/testing by & seroprevalence of HIV-1 among, pregnant women in rural south India
    N M Samuel
    The Tamil Nadu Dr M G R Medical University, Chennai, India
    Indian J Med Res 125:49-64. 2007
    ....
  9. ncbi Chronic administration of nevirapine during pregnancy: impact of pregnancy on pharmacokinetics
    E V Capparelli
    San Diego Schools of Medicine and Pharmacy and Pharmaceutical Sciences, University of California, San Diego, CA 92103, USA
    HIV Med 9:214-20. 2008
    ..To determine the impact of pregnancy on the pharmacokinetics (PK) of nevirapine (NVP) during chronic dosing in HIV-infected women and appropriate NVP dosing in this population...